denkapparat Operations GmbH purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 10,432 shares of the pharmacy operator’s stock, valued at approximately $97,000.
Several other hedge funds also recently made changes to their positions in WBA. Brooklyn Investment Group boosted its holdings in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after purchasing an additional 830 shares during the last quarter. First Financial Corp IN boosted its stake in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the last quarter. CWA Asset Management Group LLC grew its holdings in shares of Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after acquiring an additional 1,084 shares in the last quarter. Metis Global Partners LLC increased its position in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock valued at $222,000 after acquiring an additional 1,118 shares during the last quarter. Finally, Harbour Investments Inc. raised its holdings in Walgreens Boots Alliance by 4.3% during the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator’s stock worth $265,000 after acquiring an additional 1,165 shares in the last quarter. 58.59% of the stock is owned by institutional investors.
Analyst Ratings Changes
WBA has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the company from $11.00 to $9.00 in a research note on Friday, February 28th. StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Wednesday. They set a “hold” rating on the stock. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Finally, Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $10.59.
Walgreens Boots Alliance Trading Up 0.3 %
Shares of NASDAQ:WBA opened at $11.19 on Friday. The stock has a market cap of $9.67 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $21.74. The business has a 50 day moving average of $10.83 and a 200-day moving average of $9.90.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.66 EPS. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories
- Five stocks we like better than Walgreens Boots Alliance
- What is a Death Cross in Stocks?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Bank Stocks – Best Bank Stocks to Invest In
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- 3 Warren Buffett Stocks to Buy Now
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.